Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on March 13, 2012. The filing serves as a Regulation FD disclosure regarding upcoming communications between company officers and securities analysts/investors scheduled between March 13, 2012, and March 23, 2012.
Key Financial Metrics
The filing does not provide specific historical financial data such as revenue, profit, cash flow, margins, debt, or liquidity for the current or prior periods. The only financial metric disclosed is a forward-looking guidance figure.
Material Changes
No material changes to financial results or operations are reported in this document. The filing is strictly informational regarding the reaffirmation of existing guidance.
Guidance, Outlook, and Risks
Management Guidance
- Officers expect to reaffirm full-year 2012 net income guidance of at least $7.60 per share.
Risks and Contingencies
The filing includes a comprehensive Safe Harbor statement identifying numerous risks that could cause actual results to differ from projections, including:
- Impact of the Patient Protection and Affordable Care Act and related regulations.
- Trends in health care costs, utilization rates, and premium rate approvals.
- Competitor pricing and changes in product mix or enrollment.
- Risks related to Medicare and Medicaid programs, including funding and compliance.
- Financial strength rating downgrades and litigation outcomes.
- Performance of the Express Scripts, Inc. pharmacy benefit management agreement.
- Information system failures, data breaches, and Blue Cross and Blue Shield license issues.
- Impairment of intangible assets and general economic downturns.
Investor Verification Checklist
- Verify the full-year 2012 net income per share guidance of at least $7.60 in subsequent earnings releases.
- Review the company's most recent 10-K or 10-Q for historical financial performance not included in this 8-K.
- Monitor regulatory developments regarding the Affordable Care Act and their specific impact on WellPoint's operations.
- Assess the status of the Express Scripts, Inc. agreement and any potential penalties or service disruptions.